Glutaminolysis of CD4+T Cells: A Potential Therapeutic Target in Viral Diseases

被引：4

作者：

Xu, Yushan ^{[1
]}

Li, Miaomiao ^{[1
]}

Lin, Mengjiao ^{[1
]}

Cui, Dawei ^{[1
]}

Xie, Jue ^{[1
]}

机构：

[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Blood Transfus, Hangzhou 310003, Zhejiang, Peoples R China

来源：

JOURNAL OF INFLAMMATION RESEARCH | 2024年 / 17卷

基金：

中国国家自然科学基金;

关键词：

CD4+T cells; viral diseases; glutamine; glutaminolysis; immune response; HERPES-SIMPLEX-VIRUS; REGULATORY T-CELLS; METABOLIC-CONTROL; T(H)17 CELLS; TH17; CELLS; REACTIVATION; GENERATION; AUTOIMMUNE; EXPRESSION; SIGNATURE;

D O I：

10.2147/JIR.S443482

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

CD4+ T cells play a critical role in the pathogenesis of viral diseases, which are activated by the internal metabolic pathways encountering with viral antigens. Glutaminolysis converts glutamine into tricarboxylic acid (TCA) circulating metabolites by alpha-ketoglutaric acid, which is essential for the proliferation and differentiation of CD4+ T cells and plays a central role in providing the energy and structural components needed for viral replication after the virus hijacks the host cell. Changes in glutaminolysis in CD4+ T cells are accompanied by changes in the viral status of the host cell due to competition for glutamine between immune cells and host cells. More recently, attempts have been made to treat tumours, autoimmune diseases, and viral diseases by altering the breakdown of glutamine in T cells. In this review, we will discuss the current knowledge of glutaminolysis in the CD4+ T cell subsets from viral diseases, not only increasing our understanding of immunometabolism but also providing a new perspective for therapeutic target in viral diseases.

引用

页码：603 / 616

页数：14

共 134 条

[1] The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation [J].

Abrahams, Melissa-Rose ;

Joseph, Sarah B. ;

Garrett, Nigel ;

Tyers, Lynn ;

Moeser, Matthew ;

Archin, Nancie ;

Council, Olivia D. ;

Matten, David ;

Zhou, Shuntai ;

Doolabh, Deelan ;

Anthony, Colin ;

Goonetilleke, Nilu ;

Karim, Salim Abdool ;

Margolis, David M. ;

Pond, Sergei Kosakovsky ;

Williamson, Carolyn ;

Swanstrom, Ronald .

SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (513)

[2] Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? [J].

Al-Dujaili, Lena J. ;

Clerkin, Patrick P. ;

Clement, Christian ;

McFerrin, Harris E. ;

Bhattacharjee, Partha S. ;

Varnell, Emily D. ;

Kaufman, Herbert E. ;

Hill, James M. .

FUTURE MICROBIOLOGY, 2011, 6 (08) :877-907

[3] Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity [J].

Arensman, Michael D. ;

Yang, Xiaoran S. ;

Leahy, Danielle M. ;

Toral-Barza, Lourdes ;

Mileski, Mary ;

Rosfjord, Edward C. ;

Wang, Fang ;

Deng, Shibing ;

Myers, Jeremy S. ;

Abraham, Robert T. ;

Eng, Christina H. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (19) :9533-9542

[4] Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis [J].

Baxter, Victoria K. ;

Glowinski, Rebecca ;

Braxton, Alicia M. ;

Potter, Michelle C. ;

Slusher, Barbara S. ;

Griffin, Diane E. .

VIROLOGY, 2017, 508 :134-149

[5] Tregs in Autoimmunity: Insights Into Intrinsic Brake Mechanism Driving Pathogenesis and Immune Homeostasis [J].

Bednar, Kyle J. ;

Lee, Jee Ho ;

Ort, Tatiana .

FRONTIERS IN IMMUNOLOGY, 2022, 13

[6] Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV [J].

Benito, Jose M. ;

Restrepo, Clara ;

Garcia-Foncillas, Jesus ;

Rallon, Norma .

FRONTIERS IN IMMUNOLOGY, 2023, 14

[7] Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment [J].

Benito-Lopez, Jesus J. ;

Marroquin-Mucino, Mario ;

Perez-Medina, Mario ;

Chavez-Dominguez, Rodolfo ;

Aguilar-Cazares, Dolores ;

Galicia-Velasco, Miriam ;

Lopez-Gonzalez, Jose S. .

FRONTIERS IN ONCOLOGY, 2023, 12

[8] Elevated CD4+ T-cell glucose metabolism in HIV plus women with diabetes mellitus [J].

Butterfield, Tiffany R. ;

Hanna, David B. ;

Kaplan, Robert C. ;

Xue, Xiaonan ;

Kizer, Jorge R. ;

Durkin, Helen G. ;

Kassaye, Seble G. ;

Nowicki, Marek ;

Tien, Phyllis C. ;

Topper, Elizabeth T. ;

Floris-Moore, Michelle A. ;

Titanji, Kehmia ;

Fischl, Margaret A. ;

Heath, Sonya ;

Palmer, Clovis S. ;

Landay, Alan L. ;

Anzinger, Joshua J. .

AIDS, 2022, 36 (10) :1327-1336

[9] Metabolic requirements of Th17 cells and of B cells: Regulation and defects in health and in inflammatory diseases [J].

Bystrom, Jonas ;

Taher, Taher E. ;

Henson, Sian M. ;

Gould, David J. ;

Mageed, Rizgar A. .

FRONTIERS IN IMMUNOLOGY, 2022, 13

[10] HIV-1 elite controllers present a high frequency of activated regulatory T and Th17 cells [J].

Caetano, Diogo G. ;

de Paula, Hury H. S. ;

Bello, Gonzalo ;

Hoagland, Brenda ;

Villela, Larissa M. ;

Grinsztejn, Beatriz ;

Veloso, Valdilea G. ;

Morgado, Mariza G. ;

Guimaraes, Monick L. ;

Cortes, Fernanda H. .

PLOS ONE, 2020, 15 (02)

← 1 2 3 4 5 6 7 8 9 10 →